NASDAQ: SLRXSalarius Pharmaceuticals Inc Stock Ownership - Who owns Salarius Pharmaceuticals?
Insider buying vs selling
Have Salarius Pharmaceuticals Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when SLRX insiders and whales buy or sell their stock.
SLRX Shareholders
What type of owners hold Salarius Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Christoph H. Westphal | 476.06% | 8,310,759 | $5.80M | Insider |
| Boston Foundation Inc | 126.02% | 2,200,000 | $1.54M | Insider |
| Roderick MacKinnon | 24.70% | 431,277 | $301.03k | Insider |
| Jonathan P. Northrup | 20.20% | 352,713 | $246.19k | Insider |
| Barton Pk LLC | 5.73% | 100,000 | $69.80k | Insider |
| John Sculley | 3.39% | 59,111 | $41.26k | Insider |
| Thomas 1. Wessel | 3.27% | 57,064 | $39.83k | Insider |
| David J. Arthur | 2.81% | 49,135 | $34.30k | Insider |
| Scott Jordan | 1.81% | 31,609 | $22.06k | Insider |
| Mark J. Rosenblum | 1.25% | 21,851 | $15.25k | Insider |
SLRX vs Biotech Stocks
Salarius Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.